IJF.F ICON Public Limited Company

Healthcare Biotechnology Frankfurt Exchange
178.90 EUR
Close of Nov 13, 2026
66.26 192.00
Market cap
EUR 13.4B
P/E
83.2x
P/B
1.65x
ROE
4.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is IJF.F undervalued?

Graham number
Price178.90
Graham value72.50
Premium146.8%

IJF.F trades 146.8% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

ICON Public Limited Company fundamental analysis

No fundamental analysis for ICON Public Limited Company yet.

ICON Public Limited Company stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About ICON Public Limited Company

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of developmen…

Full company profile